MyFinsight
Home
Blog
About
Receivable from issuance of
warrants
$2,684,904
Cash and cash
equivalents
$2,388,135
(-57.13%↓ Y/Y)
Prepaid expenses and
other current assets
$410,105
(14.44%↑ Y/Y)
Deferred offering costs
$95,674
(300.96%↑ Y/Y)
Interest receivable
$5,305
(-72.14%↓ Y/Y)
Total current assets
$5,584,123
(-6.49%↓ Y/Y)
Property, plant and
equipment, net
$2,675
(-37.46%↓ Y/Y)
Other assets
$2,167
(0.00%↑ Y/Y)
Total assets
$5,588,965
(-6.51%↓ Y/Y)
Total liabilities and
stockholders equity
$5,588,965
(-6.51%↓ Y/Y)
Total stockholders
equity
$4,091,708
(-4.82%↓ Y/Y)
Total liabilities
$1,497,257
(-10.85%↓ Y/Y)
Accumulated deficit
-$44,779,250
(-34.73%↓ Y/Y)
Additional paid-in capital
$48,867,860
(30.20%↑ Y/Y)
Total current
liabilities
$1,497,257
(-10.85%↓ Y/Y)
Common stock, 0.001 par
value 75,000,000...
$3,098
(54.44%↑ Y/Y)
Accounts payable
$871,913
(-2.65%↓ Y/Y)
Accrued liabilities
$625,344
(-20.23%↓ Y/Y)
Back
Back
Balance Sheet
Cadrenal Therapeutics, Inc. (CVKD)
Cadrenal Therapeutics, Inc. (CVKD)
source: myfinsight.com